Product

Pfs230D1-EPA/Matrix-M Vaccine

1 clinical trial

1 indication

Indication

Clinical trial

Phase 1, Dose-Escalating, Double-Blind, Randomized, Comparator-Controlled Trial of the Safety, Tolerability, and Immunogenicity of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M™ Against Plasmodium Falciparum in Adults in Mali

Status: Completed, Estimated PCD: 2023-02-17